# Diurnal Variation in Hypertensive Stroke Patients

> **NCT01830517** · PHASE4 · COMPLETED · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 84 (actual)

## Conditions studied

- Hypertension
- Stroke

## Interventions

- **DRUG:** Amlodipine, Losartan

## Key facts

- **NCT ID:** NCT01830517
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2011-06
- **Final completion:** 2012-02
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2013-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01830517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01830517, "Diurnal Variation in Hypertensive Stroke Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01830517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*